Established in 2005 and based in Hopkinton, Massachusetts, Phosphorex offers comprehensive services in the development and manufacturing of particle-based drug delivery systems. The company supports pharmaceutical and biotechnology clients across all stages of development, from proof of concept through to clinical trials. With a commitment to innovation, Phosphorex leverages its expertise in lipid and polymer nanoparticle technologies to enhance the efficacy, targeting, and bioavailability of therapeutic agents.

Key Products and Services:

• Lipid Nanoparticles (LNPs): Specialised in the formulation and development of LNPs for the delivery of nucleic acids, including mRNA, siRNA, and plasmid DNA.

• Polymeric Nanoparticles (PNPs): Development of polymeric nanoparticles for targeted drug delivery applications.

• Polymeric Microspheres: Formulation of microspheres for sustained-release drug delivery systems.

• Formulation Feasibility & Optimization: Services to assess and optimise formulation strategies for various drug delivery systems.

• Process Development & Scale-up: Support in the development and scaling of manufacturing processes to meet clinical and commercial requirements.

• Analytical Services: Provision of analytical testing and characterization to ensure the quality and stability of drug delivery systems.

With a robust portfolio of drug delivery solutions and a focus on advancing therapeutic technologies, Phosphorexcontinues to play a pivotal role in the development of next-generation medicines. The company’s dedication to innovation and quality positions it as a valuable partner for pharmaceutical and biotech companies seeking to enhance the delivery and efficacy of their therapeutic agents.